Overview

A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants

Status:
COMPLETED
Trial end date:
2024-11-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate Deucravacitinib concentrations in the breast milk and plasma of healthy lactating female participants.
Phase:
PHASE4
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
deucravacitinib